Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

PURPOSE: Anti-GD2 monoclonal antibody (MoAb) combined with granulocyte-macrophage colony-stimulating factor (GM-CSF) has shown efficacy against neuroblastoma (NB). Prognostic variables that could influence clinical outcome were explored. PATIENTS AND METHODS: One hundred sixty-nine children diagnose...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Cheung, Nai-Kong V., Cheung, Irene Y., Kushner, Brian H., Ostrovnaya, Irina, Chamberlain, Elizabeth, Kramer, Kim, Modak, Shakeel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2012
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434986/
https://ncbi.nlm.nih.gov/pubmed/22869886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.41.3807
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller